Karl‐Erik Andersson

Active 1977–2024

Also published as
Karl Erik Andersson · Karl-Erik Andersson
136
Papers
23,023
Citations
94
h-index
133
i10-index

Citations

Citations per year for Karl‐Erik Andersson1977: 2 citations1978: 3 citations1980: 1 citations1981: 3 citations1982: 11 citations1983: 9 citations1984: 14 citations1985: 26 citations1986: 24 citations1987: 16 citations1988: 27 citations1989: 24 citations1990: 29 citations1991: 17 citations1992: 20 citations1993: 27 citations1994: 31 citations1995: 44 citations1996: 25 citations1997: 42 citations1998: 37 citations1999: 62 citations2000: 79 citations2001: 80 citations2002: 102 citations2003: 89 citations2004: 101 citations2005: 102 citations2006: 128 citations2007: 151 citations2008: 102 citations2009: 145 citations2010: 110 citations2011: 152 citations2012: 120 citations2013: 139 citations2014: 97 citations2015: 79 citations2016: 60 citations2017: 50 citations2018: 61 citations2019: 338 citations2020: 323 citations2021: 276 citations2022: 186 citations2023: 140 citations2024: 268 citations2025: 64 citations2026: 1 citations1979: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,100 citing papers, 25.8% of this breakdownUnited Kingdom: 378 citing papers, 8.9% of this breakdownChina: 282 citing papers, 6.6% of this breakdownGermany: 272 citing papers, 6.4% of this breakdownItaly: 219 citing papers, 5.1% of this breakdownSweden: 193 citing papers, 4.5% of this breakdownJapan: 174 citing papers, 4.1% of this breakdownCanada: 143 citing papers, 3.3% of this breakdownNetherlands: 142 citing papers, 3.3% of this breakdownAustralia: 110 citing papers, 2.6% of this breakdownFrance: 94 citing papers, 2.2% of this breakdownSpain: 78 citing papers, 1.8% of this breakdown
0%25.8%Other 25.4%

Fields

  • Medicine76%
  • Biochemistry, Genetics and Molecular Biology13.6%
  • Neuroscience6.9%
  • Psychology0.7%
  • Engineering0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Other1.8%

Topics

  • Urinary Bladder and Prostate Research14.6%
  • Pelvic floor disorders treatments8.9%
  • Sexual function and dysfunction studies5.5%
  • Urinary Tract Infections Management3.6%
  • Hormonal and reproductive studies3.2%
  • Nitric Oxide and Endothelin Effects2.3%
  • Other61.9%

Coauthors

All papers

Open in search
  1. Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology

    Authors: , - Physiological Reviews 2004 cited by 939

  2. 6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL INCONTINENCE

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adrian Wagg, Todd H. Wagner, Alan Wein - Neurourology and Urodynamics 2018 cited by 1,106

  3. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

    Authors: , , , , , , , , , , - British Journal of Pharmacology 2006 cited by 632

  4. Mechanisms of Penile Erection and Basis for Pharmacological Treatment of Erectile Dysfunction

    Authors: - Pharmacological Reviews 2011 cited by 383

  5. Urothelial Signaling

    Authors: , - Physiological Reviews 2013 cited by 431

  6. Urine Derived Cells are a Potential Source for Urological Tissue Reconstruction

    Authors: , , , , , , - The Journal of Urology 2008 cited by 385

  7. Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , S. Tekgul, J.W. Thüroff, Andrea Tubaro, David B. Vodušek, Alan Wein, Jean‐Jacques Wyndaele - Neurourology and Urodynamics 2009 cited by 1,092

  8. Lamina propria: The functional center of the bladder?

    Authors: , - Neurourology and Urodynamics 2013 cited by 147

  9. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders

    Authors: , , , , , , , , - Pharmacological Reviews 2023 cited by 51

  10. Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction

    Authors: , , , , , , , , , , , - The Journal of Sexual Medicine 2010 cited by 460

  11. Determinates of muscle precursor cell therapy efficacy in a nonhuman primate model of intrinsic urinary sphincter deficiency

    Authors: , , , , , - Stem Cell Research & Therapy 2017 cited by 83

  12. Chronic bladder ischemia and oxidative stress: New pharmacotherapeutic targets for lower urinary tract symptoms

    Authors: , , - International Journal of Urology 2014 cited by 113

  13. Muscarinic receptor antagonists for overactive bladder

    Authors: , - British Journal of Urology 2007 cited by 403

  14. Distribution and Function of the Hydrogen Sulfide–Sensitive TRPA1 Ion Channel in Rat Urinary Bladder

    Authors: , , , , , , , , - European Urology 2007 cited by 305

  15. Characterization of Urine-Derived Stem Cells Obtained from Upper Urinary Tract for Use in Cell-Based Urological Tissue Engineering

    Authors: , , , , , , - Tissue Engineering Part A 2011 cited by 185

  16. Are oxidative stress and ischemia significant causes of bladder damage leading to lower urinary tract dysfunction? Report from the ICI‐RS 2019

    Authors: , , , , , , , - Neurourology and Urodynamics 2020 cited by 41

  17. Oxidative Stress and Its Relation to Lower Urinary Tract Symptoms

    Authors: - International Neurourology Journal 2022 cited by 17

  18. Animal Modelling of Interstitial Cystitis/Bladder Pain Syndrome

    Authors: , - International Neurourology Journal 2018 cited by 77

  19. Gene Therapy for Overactive Bladder: A Review of BK-Channel α-Subunit Gene Transfer

    Authors: , , , , - Therapeutics and Clinical Risk Management 2021 cited by 18

  20. Defective smooth muscle regulation in cGMP kinase I‐deficient mice

    Authors: , , , , , , , , , , , , , , - The EMBO Journal 1998 cited by 502

  21. Antimuscarinics for treatment of overactive bladder

    Authors: - The Lancet Neurology 2003 cited by 415

  22. EAU Guidelines on Urinary Incontinence

    Authors: , , , , , , , , , - Actas Urológicas Españolas (English Edition) 2010 cited by 389

  23. Bladder activation: afferent mechanisms

    Authors: - Urology 2002 cited by 358

  24. Erectile Physiological and Pathophysiological Pathways Involved in Erectile Dysfunction

    Authors: - The Journal of Urology 2003 cited by 234